Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention : rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1573105974098302592
  • NII Article ID
    20001500596
  • Data Source
    • CiNii Articles

Report a problem

Back to top